C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia. - Wikidata - awgldk - TriplyDB

C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia.

C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia.

http://www.wikidata.org/entity/Q34368778

about

The fungal pattern recognition receptor, Dectin-1, and the associated cluster of C-type lectin-like receptors Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine production Long circulating lectin conjugated paclitaxel loaded magnetic nanoparticles: a new theranostic avenue for leukemia therapy IBC's 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics international conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CA Identification of CLEC12B, an inhibitory receptor on myeloid cells.Enhanced ADCC activity of affinity maturated and Fc-engineered mini-antibodies directed against the AML stem cell antigen CD96.Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity.Identification of heptapeptides interacting with IFN-α-sensitive CML cells.Nanomicelle formulation modifies the pharmacokinetic profiles and cardiac toxicity of daunorubicin Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia.Inhibitory C-type lectin receptors in myeloid cells.Right on target: eradicating leukemic stem cells.Selection strategies for anticancer antibody discovery: searching off the beaten path.Signaling by myeloid C-type lectin receptors in immunity and homeostasis C-type lectin-like receptors on myeloid cells.Can immunotherapy specifically target acute myeloid leukemic stem cells?Characterisation of murine MICL (CLEC12A) and evidence for an endogenous ligand.Targeting the leukemic stem cell: the Holy Grail of leukemia therapy Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells.Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia.Understanding of leukemic stem cells and their clinical implications.Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.CD123 targeting oncolytic adenoviruses suppress acute myeloid leukemia cell proliferation in vitro and in vivo.CD64-directed microtubule associated protein tau kills leukemic blasts ex vivo.Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells.Recent advances in acute myeloid leukemia stem cell biology Acute myelogenous leukemia stem cells: from Bench to Bedside.Sensitivity of minimal residual disease in acute myeloid leukaemia in first remission--methodologies in relation to their clinical situation.The C-type lectin-like receptors of Dectin-1 cluster in natural killer gene complex.TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia.TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells.Targeting antigens to dendritic cell receptors for vaccine development Modulation of monosodium urate crystal-induced responses in neutrophils by the myeloid inhibitory C-type lectin-like receptor: potential therapeutic implications.Recent developments in immunotherapy of acute myeloid leukemia.An anti-CD3/anti-CLL-1 bispecific antibody for the treatment of acute myeloid leukemia.Targeting human C-type lectin-like molecule-1 (CLL1) with a bispecific antibody for immunotherapy of acute myeloid leukemia Antibody-Based Treatment of Acute Myeloid Leukemia.Acute myeloid leukemia targets for bispecific antibodies.Characterization of high-affinity peptides and their feasibility for use in nanotherapeutics targeting leukemia stem cells.Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemia.

P2860

Q24654154-435FCC84-620A-42DE-834B-FE49442FC47F Q24685926-B044C2D2-DB26-46E2-AB40-7DEDD2CF3EC6 Q28477996-041663BD-A498-43AF-B248-790EB331E144 Q28660580-AE78FBC3-ABD9-473E-A70A-B44820589A60 Q30981925-5269C86B-896B-45D4-BB13-CD1968BEA6D3 Q31083322-E38EF27B-BAE3-4E4F-BE7F-AA6DCC6D43DC Q33758969-982D4F3D-FF14-4123-A742-2845D74CC8DF Q34076524-2870C558-FD0C-4557-822F-1743B11C3B02 Q34205189-219DB3B1-BA17-4F5B-B5AB-6E9DD150322C Q34232877-425B9337-8E80-4503-BCB3-59D0AA53ADB9 Q34700805-7651FCA7-3C23-4CD3-AD34-015B0966FDFD Q35132225-5585BF26-31C6-4AAC-B7B9-848F0A2512DC Q35589427-B1EF00DF-3ACE-4E4A-9D50-4902A4EB8292 Q35779708-339F6246-F43A-48AC-9037-70CA37D6F0BE Q36497532-8EF6CEEE-B8C8-4837-BCE3-74F6148F795C Q36694901-6907A0FE-AFC4-483B-90FA-D9CA46C64228 Q36725571-45BB5052-316A-4B8C-AE70-6253502B304D Q37272565-3837F058-6AA6-419C-87BD-E149879BCFFD Q37297755-1138B23D-08A9-4810-A65E-F56ECAAC49C5 Q37362705-A5468069-2063-43FA-8D2B-FD3731DF12D8 Q37616010-61DDC15B-1265-4792-A201-63153F171295 Q37628931-535480EE-82C8-4F92-9B50-7F87360CD620 Q37679277-8E99B137-C7D6-481A-9D12-4589430E90E6 Q37687139-1AD597FB-0A73-4D9E-A040-9EC737D1B321 Q37809460-78C155F2-DA36-4B0E-A5D7-A8F687E19C31 Q38003359-1011DCC4-3F11-475B-B40C-AD14B8773783 Q38020081-29654147-2F14-4A22-A18B-01D84E204581 Q38022075-EF5E6ED0-2076-4019-A02A-0EAE8A5E8E0C Q38025997-B2F85BA6-A047-4300-9530-DEFCF59FF731 Q38035447-C4F32FA1-BC41-4D16-89D0-D8631B974697 Q38138901-FE5522E5-FDDD-432C-8C63-5312A27C5CE0 Q38162446-A3BC20B9-DCB0-4A4C-8395-E1211891AAC6 Q38649946-72913BA6-9E32-4FE1-AD9C-56890ED6AC44 Q38661895-9FB7CE67-57F8-48B1-9CD6-400D4319E402 Q38727986-F444CEB1-CB42-4B2B-A76A-32712EB2A88F Q38972314-2AADD996-189D-405F-AE35-8DD9D0F6808E Q38979277-570CA192-154A-49E9-81EC-078C101C10B8 Q39117761-8B818BB3-9FEF-438A-9814-D011318A3B95 Q39422677-8746492C-E3DE-4750-92FB-FF434F37D6C1 Q39817951-4D1FA170-8A40-4D57-82AB-09F7496E211B

P2860

C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia.

http://www.wikidata.org/entity/Q34368778

description

2004 nî lūn-bûn

@nan

2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.

@ast

C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.

@en

C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.

@nl

type

label

C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.

@ast

C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.

@en

C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.

@nl

prefLabel

C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.

@ast

C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.

@en

C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.

@nl

P1433

Q34368778-6BBAE82C-F195-4A01-99C5-3B634602F16A

P1476

Q34368778-4923B3CE-8C39-4FC9-9A25-C461675495ED

P2093

Q34368778-18D47A68-FFD5-4892-ADA0-F5DD5DD16D35

Q34368778-1BEA8E03-5301-4BDA-A81A-D3B27B8832FA

Q34368778-325AC7F0-82B8-4F6A-AFB5-699A2CA5715B

Q34368778-46260795-F8DC-453F-B4DD-FC02134C5723

Q34368778-6540C2F5-7E14-425D-A4C2-0B324AE04563

Q34368778-68BE3CD8-78A3-4015-824C-EC6C3B8979A7

Q34368778-69230744-F14F-4F4B-9064-8EC0A4BFE37A

Q34368778-6A072539-86F6-4321-B122-7D3610F2FF4F

Q34368778-92B58601-20E7-4A22-A7BD-01926D138810

Q34368778-AE1EBE5D-9D32-443A-A564-90796F8AFC8A

P304

Q34368778-DA1ADE43-EF49-4A60-B0A8-C0E66AB8DD3C

P31

Q34368778-E6B23E96-687D-4C9C-ADEE-E7697A625C38

P356

Q34368778-FAC38988-31D4-44C5-85FC-968A29495667

P407

Q34368778-CFFAE919-2F11-41E9-B97E-1BD4548A3BF6

P433

Q34368778-4A842F8C-D02F-4C72-8147-F1DF99B9F304

P478

Q34368778-FF22F417-79BA-459F-A124-6B03C8EF5D2E

P50

Q34368778-35651046-4F71-4273-8CE6-CAD8D1AD165C

Q34368778-F055A395-AF3C-4F77-B8A4-E7953C56B125

P577

Q34368778-9C4E5488-940E-4874-B832-76F98470B8EF

P698

Q34368778-661045E5-84CE-439C-B79E-9DEB73921080

P921

Q34368778-92795D9B-49DB-4625-A1EB-A8E6CEA4FB9F

P356

0008-5472.CAN-04-1659

P1433

Cancer Research

P1476

C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.

@en

P2093

Ada M Kruisbeek

http://www.w3.org/2001/XMLSchema#string

Alexander B H Bakker

http://www.w3.org/2001/XMLSchema#string

Arjen Q Bakker

http://www.w3.org/2001/XMLSchema#string

Cecilia A W Geuijen

http://www.w3.org/2001/XMLSchema#string

Gerrit Jan Schuurhuis

http://www.w3.org/2001/XMLSchema#string

Gert J Ossenkoppele

http://www.w3.org/2001/XMLSchema#string

John de Kruif

http://www.w3.org/2001/XMLSchema#string

Judith A Bia

http://www.w3.org/2001/XMLSchema#string

Katarina Radosevic

http://www.w3.org/2001/XMLSchema#string

Mandy A C Jongeneelen

http://www.w3.org/2001/XMLSchema#string

P304

8443-8450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-04-1659

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

Sonja van den Oudenrijn

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15548716

http://www.w3.org/2001/XMLSchema#string

P921